Innovation in Probiotics and CDMO Solutions
At Zinereo Pharma, we are leaders in the development and manufacturing of pharmaceutical-grade probiotics designed to improve health and well-being. Our probiotic product line is built around the concept of Everything starts in the gut. We organize our portfolio according to the different gut-related axes for each therapeutic line: the gut–women’s health axis (covering fertility, gynecology, and female urology), the gut–respiratory axis (addressing both pediatric and adult populations), the gut–immune axis, and others. Our commitment to science and innovation positions us as a benchmark in the probiotics sector.
With over 80 years of experience in the pharmaceutical industry, we combine our expertise in biotechnology and microbiota to offer innovative solutions that make a difference in both human and animal health.
We are proud to offer a portfolio of more than 15 innovative products available in over 20 countries—LATAM, Middle East, Europe, Africa, and Asia—while continuing to develop new solutions for future health challenges. In addition to our probiotic portfolio, we provide customized CDMO services, from development to manufacturing, helping our clients bring their products to market with quality and efficiency.
| Sales markets | Africa; Asia; Central/South America; Middle East |
|---|---|
| Affiliated categories: | Other Microorganisms & Probiotics |Other Prebiotics |Biotic products More |